Michael Zinda
Chief Tech/Sci/R&D Officer at REPARE THERAPEUTICS INC.
Net worth: 338 687 $ as of 2024-03-30
Profile
Michael Zinda is currently the Chief Scientific Officer & Executive VP at Repare Therapeutics, Inc. He previously worked at AstraZeneca PLC as the Executive Director & Head-Cancer Bioscience from 2001 to 2017, and at Repare Therapeutics USA, Inc. as the Executive VP, Head-Research & Development from 2017 to 2019.
Dr. Zinda holds a doctorate degree from Vanderbilt University and an undergraduate degree from Minnesota State University Moorhead.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
REPARE THERAPEUTICS INC.
0.17% | 2024-03-31 | 71,908 ( 0.17% ) | 338 687 $ | 2024-03-30 |
Michael Zinda active positions
Companies | Position | Start |
---|---|---|
REPARE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2019-04-30 |
Former positions of Michael Zinda
Companies | Position | End |
---|---|---|
Repare Therapeutics USA, Inc. | Chief Tech/Sci/R&D Officer | 2019-04-30 |
ASTRAZENECA PLC | Director/Board Member | 2017-04-30 |
Training of Michael Zinda
Vanderbilt University | Doctorate Degree |
Minnesota State University Moorhead | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
REPARE THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
Repare Therapeutics USA, Inc. |
- Stock Market
- Insiders
- Michael Zinda